Portal de investigación
ESTUDIO FASE III, MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO, CON CONTROL ACTIVO PARA EVALUAR LA SEGURIDAD Y EFICACIA DE ROLAPITANT EN LA PREVENCIÓN DE NÁUSEAS Y VÓMITOS INDUCIDOS POR LA QUIMIOTERAPIA (NVIQ) EN PACIENTES QUE RECIBEN QUIMIOTERAPIA ALTAMENTE EMÉTICA (QAE)
Datos básicos
- Protocolo:
- TS-PO4833
- EUDRACT:
- 2010-022743-37
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Año de incio:
- 2012
- Año de finalización:
- 2013
Objetivos del proyecto
Observaciones: Estado Comité: FINALIZADO
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
Resultados del Ensayo Clínico
[Detection of dysphagia in the institutionalised elderly].
Ferrero Lopez, Maria Isabel; (...); Juan Vidal, Oscar
Article. 10.1016/j.regg.2011.09.004. 2012
Adjuvant therapy with bemiparin in patients with limited-stage small cell lung cancer: results from the ABEL study.
Lecumberri R; (...); Rocha E
Article. 10.1016/j.thromres.2013.09.026. 2013
EFFECT OF CYP3A5 GENOTYPE ON TACROLIMUS DOSE REQUIREMENT, NEPHROTOXICITY AND ACUTE REJECTION IN KIDNEY TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES
Rojas, L.; (...); Alino, S. F.
Article. 2013
EFFECTS OF POLYMORPHIMS OF CYP3A5 AND ABCB1 GENES ON CHRONIC NEPHROPATHY: COHORT STUDY
Rojas, L.; (...); Alino, S. F.
Article. 2013
Increased hospital stay and allograft dysfunction in renal transplant recipients with Cyp2c19 AA variant in SNP rs4244285.
Bosó V; (...); Aliño SF
Article. 10.1124/dmd.112.047977. 2013
Meta-analysis and systematic review of the effect of the donor and recipient CYP3A5 6986A>G genotype on tacrolimus dose requirements in liver transplantation.
Rojas LE; (...); Aliño SF
Article. 10.1097/FPC.0b013e3283642fb3. 2013
Paclitaxel and carboplatin treatment for advanced ovarian cancer during pregnancy.
Ruiz Ramos J; (...); Poveda JL
Article. 10.1159/000360691. 2013
Renal Transplantation Recipients with AA Genotype in SNP rs4244285 of CYP2C19 Show An Increase in Hospital Stay Duration and Allograft Dysfunction Probably Due to Increased Tacrolimus Levels Caused by Interaction with Omeprazol
Boso, V; (...); Alino, S. F.
Article. 10.1097/00007890-201211271-01757. 2012
Selective ophthalmic intra-arterial melphalan therapy for advanced retinoblastoma: implementation and outcomes of a new chemotherapy protocol.
Valero García S; (...); Poveda Andrés JL
Article. 10.1177/1078155212457964. 2013
SEOM clinical guidelines for the treatment of head and neck cancer (HNC) 2013.
Mesía R; (...); SEOM
Article. 10.1007/s12094-013-1096-z. 2013
STUDY OF THE CORRELATIONS BETWEEN SNPS IN ANGIOGENIC GENES AND TREATMENT RESPONSE/OUTCOME IN PATIENTS WITH ADVANCED NSCLC (NON-SQUAMOUS HISTOLOGY) TREATED IN FIRST LINE WITH CARBOPLATIN, PACLITAXEL AND BEVACIZUMAB (CPB). THE ANGIOMET STUDY.
Massuti, Bartomeu; (...); Camps, Carlos
Article. 2013
VEGF and TSP1 levels correlate with prognosis in advanced non-small cell lung cancer.
Fleitas T; (...); Reynés G
Article. 10.1007/s12094-013-1020-6. 2013